Results for “ ”

Entry Author Date Location
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs 06/18/20 San Diego
Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies 06/17/20 San Francisco
Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer 06/17/20 San Diego
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain” 06/09/20 Boston
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs 06/05/20 Boston
NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation 06/03/20 Boston
Grail Plants a Seed in RTP, Pledges $100M Investment in New Site 06/02/20 Raleigh Durham
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
AbCellera Raises $105M to Advance Antibody Discovery Operations 05/27/20 Seattle
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic 05/21/20 Boston
With $30M, Octant Launches Synthetic Bio Search for Multi-Target Drugs 05/20/20 San Francisco
Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases 05/19/20 New York
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System 05/14/20 New York
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline 05/14/20 New York
QurAlis Hauls In $42M to Move New ALS Therapies Into Human Testing 05/13/20 Boston
Dyno Debuts With Plan, Partnerships for Better Gene Therapy Vectors 05/11/20 Boston
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs 05/04/20 Boston
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses 05/01/20 Boston
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle 04/23/20 National
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
Page 2 of 503 « previous page · next page »